Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$33.19 -0.69 (-2.04%)
As of: Sep 9, 2026 · 12:04 PM EDT

Amylyx Pharmaceuticals (AMLX) EV to FCF (2022 - 2026)

Amylyx Pharmaceuticals (AMLX) posted EV to FCF of 55.67 for Q2 2026, down 62.51% on a QoQ basis from 34.26 in Q1 2026, and down 260.03% year-over-year from 34.79 in Q2 2025.

Analysis

Amylyx Pharmaceuticals (AMLX) EV to FCF (2022 - 2026) Analysis & Trends

Amylyx Pharmaceuticals has reported EV to FCF for 5 years, with the latest figure at 55.67 in Q2 2026.

  • On a quarterly basis, EV to FCF fell 260.03% year-over-year to 55.67 in Q2 2026; TTM through Jun 2026 was 13.81, a 485.63% decrease from a year earlier, with the FY2025 full-year figure at 8.18, down 1555.96% from the prior year.
  • EV to FCF was 55.67 for Q2 2026 at Amylyx Pharmaceuticals, down from 34.26 in the prior quarter.
  • The five-year high for EV to FCF was 324.18 in Q1 2024, with the low at 304.94 in Q1 2023.
  • Average EV to FCF over 5 years is 13.84, with a median of 17.41 recorded in 2025.
  • The sharpest annual moves came in 2023 and 2025: EV to FCF soared 779.42% in 2023, then sank 12849.47% in 2025.
  • Over 5 years, EV to FCF stood at 41.95 in 2022, then surged by 212.97% to 47.39 in 2023, then sank by 102.96% to 1.4 in 2024, then plunged by 2469.92% to 36.1 in 2025, then slumped by 54.21% to 55.67 in 2026.
  • The last three EV to FCF figures came in at 55.67 (Q2 2026), 34.26 (Q1 2026), and 36.1 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.88 Bn 197.89 Bn 7.24 Bn
2 Gilead Sciences 181.55 Bn 178.37 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.31 Bn 124.45 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn
5 Argenx Se 61.54 Bn 56.36 Bn 1.37 Bn
6 Moderna 54.69 Bn 49.55 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.07 Bn 30.76 Bn 992.69 Mn
8 Biogen 31.41 Bn 30.12 Bn 1.96 Bn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn
10 Amylyx Pharmaceuticals 3.69 Bn 3.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -55.67
Mar 31, 2026 -34.26
Dec 31, 2025 -36.10
Sep 30, 2025 -37.76
Jun 30, 2025 -15.46
Mar 31, 2025 -2.79
Dec 31, 2024 -1.40
Sep 30, 2024 0.30
Jun 30, 2024 2.71
Mar 31, 2024 324.18
Dec 31, 2023 47.39
Sep 30, 2023 -159.42
Jun 30, 2023 131.50
Mar 31, 2023 -304.94
Dec 31, 2022 -41.95
Sep 30, 2022 -34.11
Jun 30, 2022 -19.36
Mar 31, 2022 -11.92